There is evidence for the role of the cholecystokinin (CCK) neurotransmitter system in the neurobiology of panic disorder (PD).
). Also, untreated PD patients display an increased CCK-4-induced intracellular Ca 2+ mobilization in T cells relative to treated PD, depression and schizophrenia. 3 The CCK receptors have been classified into two subtypes: CCK-A and CCK-B. We report here a study of polymorphisms in the CCK pre-pro hormone gene (CCK), CCK-AR, and CCK-BR in DSM-IV panic patients (n = 99) vs controls matched for gender and ethnicity. The CCK polymorphism revealed no association with PD. We identified a new polymorphism for the CCK-A receptor gene, and tested it in our sample, with negative results. A single nucleotide polymorphism has been found in the coding region of the CCK-B receptor gene 4 (CCK-BR) and D Collier (personal communication) identified a highly polymorphic dinucleotide (CT) n microsatellite in the 5Ј regulatory region. For the CCK-B receptor gene polymorphism, PD patients showed a significant association. Our genetic dissection of the CCK system thus far suggests that the CCK-B receptor gene variation may contribute to the neurobiology of panic disorder.
Non-significant P-values were obtained for the CCK peptide gene (genotype: P = 0.915; allele: P = 0.87) and CCK-A gene (genotype: P = 0.502; allele: P = 0.58) markers. The CCK-B polymorphism showed a significant P-value for association with panic disorder, using our a priori design of grouping alleles into four categories ( 2 = 13.8, 3 d.f., P = 0.004). An analysis using all alleles (see Table 1 ) was also significant ( 2 = 26.0, 15 d.f., P = 0.038). Simulations using the Monte Carlo method 5 supported this positive association. Panic patients showed an excess of alleles 6 and 7, with odds ratios of 2.3 (95% CI 1.3-3.9) and 1.7 (95% CI 1.0-2.7), respectively. For these two risk alleles, the sum chisquare is 12.38, 2 d.f., P-value 0.002.
Our study showed no evidence that panic disorder is associated with the cholecystokinin pre-pro-hormone gene polymorphism, results that are contradictory to the recent study by Wang and colleagues 6 who reported significant findings in two populations. We also developed and examined a DNA polymorphism for CCK-AR (see Methods) and found negative results. We did find evidence supporting an association between PD and CCK-BR, suggesting a role for this gene as a modifying factor in conferring susceptibility to the disorder. In view of the location of the marker in the promoter region, variation in gene expression may cause dysregulation of the CCK system, which could result in a risk factor for panic attacks.
A limitation of this study is the use of cases and controls. This methodology is susceptible to spurious positive results due to population stratification. We attempted to prevent this by matching carefully for ethnic background, age, and sex. The large number of alleles for CCK-BR makes it more difficult to determine the role of each. It is possible for example that one or more of the alleles have a protective effect, and we currently do not have power to detect this. A final consideration is that we tested three loci and thus theoretically should correct for this by multiplying the Pvalues by the number of tests. In argument against this correction is the fact that the CCK system genes have a very good biological hypothesis behind them, and could thus be considered distinct tests that do not need correction for other tests. In any case, even with correction, our findings for CCK-BR remain significant under the a priori four-allele category design. Future work in this project will include collection of probands and both their parents in order to attempt a replication of our findings using family-based controls.
Methods

Subjects
Subjects were recruited through referrals or advertising through the Mood and Anxiety Division of the Department of Psychiatry, University of Toronto. They were invited to participate if they fulfilled criteria for PD as substantiated by a psychiatric interview and by a structured interview based on the DSM-IV (SCID). Comorbidity with other anxiety disorders or depression was allowed as long as the diagnosis of PD was primary and predominant. PD subjects (63 females and 36 males) were closely matched with controls on the basis of age, sex and ethnic ancestry. Ethnicity in both patients and controls was determined based on primary language spoken, religious affiliation and birthplace of both the proband and his or her parents. The control group consisted of healthy individuals responding to local advertisements. After complete description of the study to the subjects, written informed consent was obtained. Genomic DNA extraction was performed using standard high salt methods. .0) (3.0) (2.5) (6.6) (7.6) (10.6) (15.7) (15.7) (14.1) (3.5) (5.0) (3.0) (2.0) (1.5) (6.0) (1.0)
The percentage of each allele for this sample is listed in parentheses.
CCK peptide gene
We genotyped the polymorphism of Wang et al, 6 located in the upstream putative regulatory region of the gene that codes for the pre-pro-hormone, that is processed to yield the CCK tetra-and octa-peptides. The polymorphism consists of a C→T nucleotide change at position −36 in a GC box, a binding site for transcription factor Sp1.
CCK-AR
A polymorphism was identified, using SSCP, in the 5Ј area of the 3Ј untranslated region. The primers used were as follows: 5Ј-TGACCCTCCACCGCAGAAG-3Ј and 5Ј-AGCTCAGTAGGCCCCACATC-3Ј. PCR samples in 15× SSC (100 l volume) were slot-blotted in duplicate onto Hybond N + membrane using the Schleicher & Schuell (NH, USA) slot blot apparatus. Allele-specific oligonucleotides were designed for the variable nucleotide, generating the following sequences: 5Ј-CAGA-GAAGAAAGAAC-3Ј and 5Ј-CAGAGAAAAAAGAAC-3Ј. Hybrid-ization was done with either the common or rare ASO overnight at 36°C in Amasino buffer and the filters were washed at 38°C using 4× SSC with 0.1% SDS.
CCK-BR
A CT repeat polymorphism in the putative promoter region of CCK-BR was amplified using 150 ng of template DNA. The sequences were 5Ј-TCTAC CCAACCCCTCCTACC-3Ј and 5Ј-CACCTCCTCTTTAT-CACCCGC-3Ј. After an initial denaturation step at 95°C for 5 min, standard PCR was performed using 1.5 mM MgCl 2 , 0.2 M of 3Ј end-labelled forward primer and 0.4 M reverse primer. The PCR parameters were 94°C for 30 s, 59°C for 30 s, and 72°C for 30 s for 30 cycles. Products, of size 182-152 base pairs, were separated on a 6% denaturing polyacrylamide gel and visualized by autoradiography.
Analysis
Chi-square analyses were performed on allele and genotype counts for the CCK-AR and CCK peptide gene polymorphisms. Alleles for the CCK-B receptor were analyzed by chi-square tests first with arbitrary a priori groupings into four size categories, then an analysis of all 16 alleles. The CCK-BR data were also analyzed by the Monte Carlo method. 5 The P-values were not corrected for multiple testing. Odds ratios were calculated using the RERI program of the LINKUTIL package. 
